Drugs that contain Malathion
1. Ovide patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7560445 | TARO | Process for preparing malathion for pharmaceutical use |
Feb, 2027
(2 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7977324 | TARO | Process for preparing malathion for pharmaceutical use |
Aug, 2026
(2 years from now) | |
Market Authorisation Date: 02 August, 1982
Treatment: Treatment of patients infected with pediculus humanus capitis (head lice and their ova) of the scalp hair
Dosage: LOTION;TOPICAL
How can I launch a generic of OVIDE before it's drug patent expiration?
More Information on Dosage
OVIDE family patents
